COMMUNIQUÉS West-GlobeNewswire

Rule 2.9 Announcement

24/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 December 2018 [...]

PledPharma applies for an Orphan Drug Designation (ODD) in the US for Aladote

24/12/2018 - 08:00

Stockholm, December 24, 2018. PledPharma AB (publ) announces that the company has filed an application for an Orphan Drug Designation (ODD) to the US FDA for the drug candidate Aladote ® , developed to reduce liver [...]

Bone Therapeutics SA: Information on the total number of voting rights and shares

24/12/2018 - 07:00

Regulated information Gosselies, Belgium, 24 December 2018, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions

24/12/2018 - 07:00

Information réglementée Gosselies, Belgique, le 24 décembre 2018, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins [...]

SoldierStrong Donates State-of-the-Art Exoskeleton to the St. Louis Veterans Health Care System

23/12/2018 - 02:13

ST. LOUIS, Dec. 22, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to veterans, donated an Indego Therapy exoskeleton to the St. Louis [...]

Rahal Automotive Group Donates $40,000 to SoldierStrong to Aid Military Veterans Rehabilitating From Spinal Injuries

22/12/2018 - 18:47

PITTSBURGH, Dec. 22, 2018 (GLOBE NEWSWIRE) -- Bobby Rahal Automotive Group today donated $40,000 to SoldierStrong, a national nonprofit organization that provides state-of-the-art medical devices to aid in [...]

Helix BioPharma Corp. Closes Third Tranche of Private Placement

21/12/2018 - 23:06

RICHMOND HILL, Ontario, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore

21/12/2018 - 23:04

CHARLESTON, S.C., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc., (NASDAQ:AEZS) (TSX: AEZS) has settled its previously disclosed litigation in South Carolina and Canada with former officers of the Company, [...]

R1 RCM to Present at the 37th Annual J.P. Morgan Healthcare Conference

21/12/2018 - 23:00

CHICAGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management services to healthcare providers, today announced its management team will present at the 37 th Annual [...]

Supernus to Present at the 2019 J.P. Morgan Healthcare Conference

21/12/2018 - 22:15

ROCKVILLE, Md., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway

21/12/2018 - 22:05

‒ Histogenics to Discontinue Development of NeoCart and Explore Strategic Alternatives ‒ WALTHAM, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), today provided an update [...]

Galapagos to Present at 37th Annual J.P. Morgan Healthcare Conference

21/12/2018 - 22:02

Mechelen, Belgium; 21 December 2018, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) will participate in the 37th Annual J.P. Morgan Healthcare Conference on January 8 & 9, 2019. Onno van de Stolpe, CEO, will [...]

Ascendis Pharma A/S Announces Participation in 37th Annual J.P. Morgan Healthcare Conference

21/12/2018 - 22:01

COPENHAGEN, Denmark, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon ™ technology to address significant unmet medical needs, today [...]

Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine

21/12/2018 - 21:29

COPENHAGEN, Denmark, December 21, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for the liquid- [...]

Bonify Selects RavenQuest to Provide Management Services

21/12/2018 - 20:27

VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces it has been retained by Canadian Licensed [...]

Dentsply Sirona to Present at the 37th Annual J.P. Morgan Healthcare Conference

21/12/2018 - 20:00

YORK, Pa., Dec. 21, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq:XRAY), The Dental Solutions Company, today announced it will participate in the 37 th Annual J.P. Morgan Healthcare [...]

GBT Appoints Dawn Svoronos to Board of Directors

21/12/2018 - 19:30

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the appointment of Dawn Svoronos to the company’s board of directors. Ms. Svoronos has [...]

Fortress Biotech Recaps Corporate Highlights and Achievements in 2018

21/12/2018 - 19:17

NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Lexicon Pharmaceuticals to Present at Upcoming Investor Conference

21/12/2018 - 18:45

THE WOODLANDS, Texas, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: 37 [...]